Title |
Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor
|
---|---|
Published in |
Psychopharmacology, December 2013
|
DOI | 10.1007/s00213-013-3368-2 |
Pubmed ID | |
Authors |
Xin Zhao, Chuang Wang, Jun-Fang Zhang, Li Liu, Ai-Ming Liu, Qing Ma, Wen-Hua Zhou, Ying Xu |
Abstract |
Comorbid depression is commonly observed in individuals who suffer from neuropathic pain, which necessitates improved treatment. Curcumin, a phenolic compound derived from Curcuma longa, possesses both antinociceptive and antidepressant-like activities in animal studies, suggesting its possible usefulness in treating this comorbidity. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
Unknown | 61 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 16% |
Student > Ph. D. Student | 9 | 15% |
Student > Bachelor | 8 | 13% |
Researcher | 5 | 8% |
Student > Doctoral Student | 4 | 6% |
Other | 12 | 19% |
Unknown | 14 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 10 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 11% |
Medicine and Dentistry | 6 | 10% |
Agricultural and Biological Sciences | 5 | 8% |
Nursing and Health Professions | 2 | 3% |
Other | 7 | 11% |
Unknown | 25 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2022.
All research outputs
#2,320,843
of 22,818,766 outputs
Outputs from Psychopharmacology
#572
of 5,348 outputs
Outputs of similar age
#28,285
of 307,149 outputs
Outputs of similar age from Psychopharmacology
#7
of 64 outputs
Altmetric has tracked 22,818,766 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,348 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.